Paul Modrich (Nobel Prize in Chemistry 2015, Duke University Medical Center, Durham, NC, USA)
Thomas C. Südhof (Nobel Prize in Medicine in Physiology 2013, University of Stanford School of Medicine, Stanford, CA, USA), pending
Avram Hershko (Nobel Prize in Chemistry 2004, The Technion-Israel Institute of Technology, Haifa, Israel)
Robert Huber (Nobel Prize in Chemistry 1988; Max-Planck-Institute, Martinsried, Germany)
Individualized medicine Program:
Ryan C. Bailey (University of Michigan, Ann Arbor, MI, USA): Microfluidic Tools for Automating Epigenetics.
Arnold Caplan (Case Western Reserve University, Cleveland, OH, USA): Mesenchymal Stem Cells: Time to Change the Name.
Henry A. Erlich (Children's Hospital Oakland Research Institute, Oakland, CA, USA): Next-generation sequencing for non-invasive prenatal diagnosis of the hemoglobinopathies: a model for autosomal recessive diseases.
Niluger Ertekin-Taner (Mayo Clinic, Jacksonville, FL, USA): Comparative –Omics in Neurodegenerative Diseases: Pathways of Convergence and Divergence.
Haojie Huang (Mayo Clinic, Rochester, MN, USA): Gene mutation, epigenetic remodeling and therapy resistance in cancer.
Manolis Kellis (MIT Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA and The Broad Institute of MIT and Harvard, Cambridge, MA, USA)
Eric Klee (Mayo Clinic, Rochester, MN, USA)
Gordan Lauc (University of Zagreb; Genos Ltd., Zagreb, Croatia): The Human Glycome Project - Exploring the new frontier in personalised medicine.
Minetta Liu (Mayo Clinic, Rochester, MN, USA): Development of circulating tumor cell- and cell-free-DNA-based assays for the management of solid tumors.
Raul Mostoslavsky (Massachusetts General Hospital Cancer Center; Harvard Medical School, Boston, MA, USA): Linking cancer, epigenetics and metabolism: lessons from SIRT6.
Grzegorz S. Nowakowski (Mayo Clinic, Rochester, MN, USA)
Tamas Ordog (Mayo Clinic, Rochester, MN, USA): Interrogating and manipulating lineage-critical enhancers for therapeutic benefit.
Dragan Primorac (The Pennsylvania State University and University of New Haven, USA; St. Catherine Hospital, Children's Hospital "Srebrnjak", Zagreb, Croatia; Universities of Split, Rijeka and Osijek, Croatia): Articular cartilage regeneration: current and future technologies.
Keith D. Robertson (Mayo Clinic, Rochester, MN, USA)
Jacques Schrenzel (Geneva University Hospital, Geneva, Switzerland): Microbiome analysis in clinical medicine: hope or hype?
Keith Stewart (Mayo Clinic, Rochester, MN, USA)
Christoph A. Thaiss (Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA)
Raul Urrutia (Medical College of Wisconsin, Milwaukee, WI, USA): Epigenomics of pancreatic cancer.
Richard Weinshilboum (Mayo Clinic, Rochester, MN, USA)
Andre van Wijnen (Mayo Clinic, Rochester, MN, USA): Epigenetics of skeletal development and mesenchymal stem cell differentiation.
Rugang Zhang (The Wistar Institute, Philadelphia, PA, USA): Approaches to SWI/SNF alterations in cancer.
Forensic Genetics and Anthropological Genetics Program:
Joshua Akey (Princeton University, Princeton, NJ, USA): Archaic human DNA in the genome of modern humans.
Frederick Bieber (Harvard Medical School, Boston, MA, USA): Geneaologics: public DNA databases in forensic investigation.
Joachim Burger (University of Mainz, Germany): Demographic and evolutionary inference from palaeogenomes.
Bruce Budowle (University of North Texas Health Science Center, Fort Worth, TX, U.S.A.): The Expansive and Dynamic Future of Forensic Genetics.
Yaniv Erlich (Columbia University, New York City, U.S.A.): The hitchhiker’s guide to breach genetic privacy.
Tom Gilbert (Centre for GeoGenetics, Natural History Museum of Denmark, University of Copenhagen, Copenhagen, Denmark): Human genetic consequences of the second plague pandemic.
Wolfgang Haak (Max Planck Institute for the Science of Human History, Jena, Germany): Into the great wide open: 3000 years of human population history in the Caucasus region.
Mitch Holland (The Pennsylvania State University, State College, PA, U.S.A.): DCMPS of mtDNA Heteroplasmy: An Established Tool for Forensic Investigations.
Melissa Ilardo (University of Utah, Salt Lake City, U.S.A.): Genetic and physiological adaptations to diving in modern humans.
Tomas Marques-Bonet (University Pompeu Fabra, Barcelona, Spain)
Mattias Jacobsson (Uppsala University, Uppsala, Sweden): Interrogating early human history using ancient DNA from Africa
Manfred Kayser (Erasmus MC University Medical Center Rotterdam, Netherlands): Improving forensic Y-chromosome analysis.
Michael Kobor (University of British Columbia, Vancouver, Canada)
Johannes Krause (Max Planck Institute for the Science of Human History, Jena, Germany)
James Landers (University of Virginia School of Medicine, Charlottesville, VA, U.S.A.): Towards fieldable, handheld DNA analyzers for ultrafast STR profiling.
Simon Mead (University College London Hospitals, London, United Kingdom): Genetic adaptation to prion diseases with a particular reference to Kuru in Papua New Guinea and CID in Europe.
Matthias Meyer (Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany): Improving techniques for the retrieval and analysis of ancient human DNA.
Ludovic Orlando (CNRS Université de Toulouse, Toulouse, France and Centre for GeoGenetics, Natural History Museum of Denmark, University of Copenhagen, Copenhagen, Denmark): From short, degraded, ancient DNA molecules to genome-wide epigenetic signatures: exploring our epigenetic past.
Walther Parson (Medical University Innsbruck, Innsbruck, Austria): Development and Validation of Basic Prototype MPS Tools to Infer Appearance, Ancestry and Age from forensic DNA samples.
Daniele Podini (George Washington University, Washington D.C., U.S.A.): Microhaplotypes: a comprehensive forensic DNA marker.
Antti Sajantila (University of Helsinki, Helsinki, Finland)
Mark Thomas (University College London, London, United Kingdom): Genetic astrology.
Zhenjiang Xu (Nanchang University, Jiangxi, China): Accurate estimates of the post-mortem interval using cadaver-associated microbiomes.